InflaRx N.V. (IFRX) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of InflaRx N.V. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IFRX
InflaRx N.V.
$1.62HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.89HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — IFRX vs NAUT
growth of $100 · dividends reinvested · last 6yIFRX -65.9% (-16.4%/yr)NAUT -82.1% (-24.9%/yr)IFRX compounded faster over this window
IFRX NAUT
IFRX vs NAUT: by the numbers
- •NAUT is the larger company ($240M vs $239M market cap).
- •Both run net losses; NAUT's is the smaller (-29747.89% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | IFRX | NAUT |
|---|---|---|
| P/S ratio | N/A | 1264.52 |
| P/B ratio | 1.43 | 1.83 |
Profitability
| Metric | IFRX | NAUT |
|---|---|---|
| Gross margin | -24677.94% | 0.00% |
| Operating margin | -164525.50% | 0.00% |
| Net margin | -155582.08% | -29747.89% |
| ROE | -27.27% | -43.11% |
| ROIC | -25.38% | -40.52% |
Growth (annualized)
| Metric | IFRX | NAUT |
|---|---|---|
| Total return CAGR (5Y) | -7.34% | -20.56% |
Frequently asked
- How have IFRX and NAUT total returns compared?
- Over the past 5 years, IFRX delivered -7.34% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.